Credit: Getty images. Post hoc analysis of the VENTURE/TRAVERSE trials assessed dupilumab efficacy in patients with severe asthma requiring varying levels of oral corticosteroids at baseline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback